The effect of CYP2C19 genetic polymorphism and non-genetic factors on clopidogrel platelets inhibition in East Asian coronary artery disease patients

被引：13
|
作者：
Amin, Arwa M. [1 ]
Chin, Lim Sheau [1 ]
Noor, Dzul Azri Mohamed [1 ]
Mostafa, Hamza [1 ]
Kader, Muhamad Ali S. K. Abdul [1 ,2 ]
Hay, Yuen Kah [1 ]
Ibrahim, Baharudin [1 ]
机构：
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Hosp Pulau Pinang, Cardiol Dept, George Town, Penang, Malaysia
来源：
THROMBOSIS RESEARCH | 2017年 / 158卷
关键词：
CYP2C19; Clopidogrel; Dual antiplatelet therapy (DAPT); Coronary artery disease patients; VerifyNow; High on treatment platelets reactivity; CLINICAL-OUTCOMES; THERAPY; IMPACT; RISK;
D O I：
10.1016/j.thromres.2017.07.032
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：22 / 24
页数：3
相关论文
共 50 条
  • [21] ASSOCIATION OF GENETIC (CYP2C19, CYP2C9 AND P2Y12 SNPS) AND NON GENETIC FACTORS WITH ANTIPLATELET EFFECT OF CLOPIDOGREL IN ISCHEMIC STROKE PATIENTS
    Gairolla, J.
    Khullar, M.
    Ahluwalia, J.
    Medhi, B.
    Kler, R.
    Modi, M.
    Khurana, D.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 55 - 56
  • [22] Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction
    Kiss, Adam Ferenc
    Vasko, Dorottya
    Deri, Mate Tamas
    Toth, Katalin
    Monostory, Katalin
    PHARMACOLOGICAL REPORTS, 2018, 70 (03) : 525 - 532
  • [23] Genetic polymorphism of CYP2C19 in Maharashtrian population
    Ghodke, Yogita
    Joshi, Kalpana
    Arya, Yashendra
    Radkar, Anjali
    Chiplunkar, Aditi
    Shintre, Pooja
    Patwardhan, Bhushan
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (12) : 907 - 915
  • [24] Genetic polymorphism of CYP2C19 in Maharashtrian population
    Yogita Ghodke
    Kalpana Joshi
    Yashendra Arya
    Anjali Radkar
    Aditi Chiplunkar
    Pooja Shintre
    Bhushan Patwardhan
    European Journal of Epidemiology, 2007, 22 : 907 - 915
  • [25] CYP2C19 Genetic Polymorphism in Saudi Arabians
    Al-Jenoobi, Fahad I.
    Alkharfy, Khalid M.
    Alghamdi, Amal M.
    Bagulb, Khawla M.
    Al-Mohizea, Abdullah M.
    Al-Muhsen, Saleh
    Halwani, Rabih
    Parvez, Mohammad Khalid
    Al-Dosari, Mohammed S.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (01) : 50 - 54
  • [26] Genetic Polymorphism of CYP2C19 in Pakistani Population
    Riaz, Sana
    Din, Sadia Muhammad
    Tareen, Muhammad Usman
    Tariq, Fizza
    Latif, Yusra
    Siddiqi, Saima
    Sultan, Aneesa
    Mansoor, Atika
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (02): : 1097 - 1102
  • [27] Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction
    Ádám Ferenc Kiss
    Dorottya Vaskó
    Máté Tamás Déri
    Katalin Tóth
    Katalin Monostory
    Pharmacological Reports, 2018, 70 : 525 - 532
  • [28] Effects of CYP2C19 genotype on vascular function in patients with coronary artery disease receiving clopidogrel
    Zaromitidou, M.
    Tousoulis, D.
    Siasos, G.
    Kioufis, S.
    Oikonomou, E.
    Maniatis, K.
    Kokkou, E.
    Mazaris, S.
    Tourikis, P.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 118 - 118
  • [29] Influence of CYP2C19 genetic variants and smoking on dual antiplatelet efficacy in patients with coronary artery disease
    Cheng, Yujing
    Sun, Yan
    Zhang, Dai
    Ma, Xiaoteng
    Liu, Chi
    Hu, Chengping
    Sun, Tienan
    Zhao, Ziwei
    Liu, Xiaoli
    Zhou, Yujie
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [30] Pharmacogenetics of CYP2C19 genetic polymorphism on clopidogrel response in patients with ischemic stroke from Saudi Arabia
    Alhazzani, Adel A.
    Munisamy, Murali
    Karunakaran, Gauthaman
    NEUROSCIENCES, 2017, 22 (01) : 31 - 37
12345